Arcutis | Zoryve | Foam Print Ad

ZORYVE® (roflumilast) foam was designed to bring advanced topical innovation to plaque psoriasis treatment—especially for areas where creams can be cumbersome or uncomfortable. The challenge: express that breakthrough formulation in a single print ad without relying on efficacy claims or clinical data.

SFC Group’s solution was to let the formulation speak for itself. The design of this journal ad brought the foam to life—light, airy, and effortless. Three-dimensional lettering mirrored the product’s texture and movement, reinforcing how ZORYVE fits seamlessly across body areas that don’t take kindly to cream. The result is a simple, sophisticated expression of ease.

Soft gradients and clean composition create a sense of lift and motion, while the restrained palette reflects purity and precision. The typography appears to float—echoing the foam’s weightless spread across skin. Every visual cue, from negative space to lighting, was intentionally crafted to translate formulation science into form. The copy remains minimal and confident—a true reminder ad that lets the design do the storytelling. Without superlatives or clutter, it conveys trust through sophistication and restraint.

In an industry crowded with dense visuals and medical jargon, this piece stands out through stillness. It invites dermatologists to pause, look closer, and feel the innovation behind ZORYVE foam for plaque psoriasis. The finished ad isn’t loud or boastful—it’s quietly confident, much like the formulation it represents: light where others are heavy, seamless where others struggle, and always designed with the patient experience in mind.